|
News, trends, and stories from the synthetic biology industry
|
|
|
Hi ,
It’s another exciting week at SynBioBeta! Today at 1-2pm PST, John Nicols will be joining us for a special discussion and live Q&A on overcoming the synthetic biology industry challenges of 2020 and how to navigate the uncertainties of a post-pandemic future. Join the Bioeconomy Hub to get access to this exclusive event!
|
|
|
|
|
Stephanie Michelsen Jellatech
|
|
|
|
Michael Selden Finless Foods
|
|
|
|
Marie Brueser Thought For Food
|
|
|
James Hury TRISH
|
|
|
|
The Unexplored Power of Microbes There are billions of microbes on Earth but right now, synthetic biology is only utilizing a select few. What unexplored microbe could
transform the future of bioengineeering? "A lot of synthetic biology has been centered around the bread and butter E. colisaccharomyces… but there are millions of [microbial] species that haven’t been tackled," says Kevin Solomon, P.h.D, assistant professor of agricultural and biological engineering at Purdue University.
|
|
|
New Synthetic Biology Venture Fund Puts "Scientist Founders" First Synthetic biology investment set a nearly $8 billion record in 2020. The trend of increased biotech
venture capital continues in 2021 with the newly announced fund NFX Bio. The firm will be led by Dr. Omri Amirav Drory, Dr. Emily Leproust, James Currier and Gigi Levy-Weiss.
|
|
|
SynBioBeta Podcast
How do we start to harness nature’s design principles and manufacturing capabilities to design new materials from the atomic level up? In our latest episode, I spoke with Massimo Portincaso about the impacts of co-designing with nature. Read BCG’s report on the bio-industrial revolution.
In case you missed it…
|
|
|
|
Looking to learn more about where the synthetic biology industry is heading? Get access to our top 9 panel discussions and hear what synthetic biology investors,
entrepreneurs, and thought leaders envision for the future of the industry:
|
|
|
|
|
|
|
|
|
|
|